M. Harada et al., CONCOMITANT IMMUNITY AGAINST TUMOR-DEVELOPMENT IS ENHANCED BY THE ORAL-ADMINISTRATION OF A KAMPO MEDICINE, HOCHU-EKKI-TO (TJ-41-BU-ZHONG-YI-QI-TANG), Immunopharmacology and immunotoxicology, 17(4), 1995, pp. 687-703
The oral administration of a kampo herbal medicine, Hochu-ekki-to (TJ-
41: Bu-Zhong-Yi-Qi-Tang) using a water-Supplying bottle resulted in a
slight but significant inhibition of Meth A growth. The oral administr
ation of TJ-41 with gastric gavage significantly enhanced the specific
antitumor activity against Meth A at rechallenge on day 9. In a tumor
-neutralizing assay, the tumor draining LN cells of the TJ-41 administ
ered mice showed an antitumor activity against Meth A. In a cytolytic
assay, the anti-Meth A specific cytolytic T lymphocyte activity was no
t detected in the spleen cells of the Meth A bearing and TJ-41 adminis
tered mice. The oral administration of TJ-41 enhanced the natural kill
er (NK) activity of the spleen cells in naive mice but could not impro
ve the decreased NK activity of spleen cells from the tumor bearing mi
ce. In a cytostatic assay, the peritoneal exudate cells from the Meth
A bearing and TJ-41 administered mice showed a significantly higher am
ount of cytostatic activity against Meth A than that from either Meth
A bearing or TJ-41 administered mice. These results indicate that the
oral administration of TJ-41 into the tumor bearing mice may thus be a
ble to enhance concomitant antitumor immunity through the augmentation
of the cytostatic activity.